• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Tyber Medical Opens $8M Office and Manufacturing Facility

    FDA OKs Shoulder Surgery 3D Planner & Positioner

    Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Orthopedic Innovation Pty. Ltd.

    Hammill Medical

    Teleflex Medical OEM

    Five Star Manufacturing Inc.

    NN Life Sciences
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Breaking News

    SpinalCyte Announces New International Patents

    Patents are related to generating chondrocyte-like cells and applying them within the spinal disc space.

    SpinalCyte Announces New International Patents
    Image courtesy of Business Wire.
    Related CONTENT
    • SpinalCyte Applies to FDA to Expand Human Clinical Trial of CybroCell Dermal Fibroblasts
    • FDA OKs Centinel Spine's FLX Platform of 3D Printed All-Titanium Interbodies
    • RTI Surgical Launches Fortilink-TS and -L IBF Systems
    • OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan
    • Aziyo Partners with SurGenTec for Minimally Invasive Bone Graft Delivery
    Business Wire11.08.18
    SpinalCyte LLC, a regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), has been issued new patents in Hong Kong and Europe. The company’s intellectual property in spine treatments now includes 35 U.S. and foreign patents issued with 41 patents pending, which provide an intellectual property estate for its lead product, CybroCell. The company’s positive results from its completed clinical trial and strong patent portfolio continue to spur interest among biotech investors for licensing and partnership opportunities.
     
    “These new patents add to our portfolio and bolster the international protections for our fibroblast technology,” said Pete O’Heeron, CEO of SpinalCyte. “SpinalCyte is at the forefront of human dermal fibroblast cell therapy, specifically in disc degeneration. We hold all intellectual property related to HDF treatment for degenerative disc disease (DDD), positioning us as the front-runner in this emerging sector of cell therapies.”
     
    The technologies described in Hong Kong Patent No. HK1197832, “Dermal Fibroblasts for Treatment of Degenerative Disc Disease,” and European Patent No. 3146939, “Composition for Repair of Cartilage Using an In Vivo Bioreactor,” related to generating chondrocyte-like cells and applying them within the spinal disc space. Additional claims surround the paracrine benefit of introducing fibroblasts to the disc environment.
     
    The new patents follow positive clinical trial results of CybroCell which show sustained pain relief in the treatment of DDD at 12 months.
     
    Degenerative disc disease is a condition in which a patient’s spinal disc breaks down and can begin to collapse. It is estimated that 85 percent of people over the age of 50 have evidence of disc degeneration and over 1.3 million procedures a year are performed to treat the disease. The most common treatments for patients with DDD are either discectomy or spinal fusion. Discectomy is the partial or full removal of the degenerated disc to decompress and relieve the nervous system but can cause long term spinal pain. In a spinal fusion procedure, the entire disc is removed and the two adjacent vertebrae are fused together. It often increases strain on the adjacent discs and surrounding tissues leading to further degeneration.
     
    CybroCell is the first off-the-shelf allogenic human dermal fibroblast (HDF) product for the treatment of degenerative disc disease. SpinalCyte’s Phase 1/Phase 2 clinical trial for injected human dermal fibroblasts in the treatment of DDD demonstrated after 12 months, patients who were injected with CybroCell had sustained improvement in pain relief and increased back mobility.
     
    Based in Houston, Texas, SpinalCyte LLC is a regenerative medicine company developing a solution for spinal disc regeneration using human dermal fibroblasts. Currently, SpinalCyte holds 35 U.S. and international issued patents and has filed for an additional 41 patents pending. SpinalCyte holds 110 U.S. and International Patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure and heart failure. The company is funded entirely by angel investors.
    Related Searches
    • discectomy
    • patent
    • ceo
    • spinal fusion
    Suggested For You
    SpinalCyte Announces Positive 12-Month Pain Data From Trial for Degenerative Disc Disease SpinalCyte Announces Positive 12-Month Pain Data From Trial for Degenerative Disc Disease
    NASS News: Spineology Presents 12-Month Data for SCOUT Trial NASS News: Spineology Presents 12-Month Data for SCOUT Trial
     Medtronic Launches the Infinity OCT Spinal System at NASS Medtronic Launches the Infinity OCT Spinal System at NASS
    FDA Clears CoreLink FDA Clears CoreLink's M3 Stand-Alone ALIF System
    NuVasive Launches TLX 20 Degree Expandable Spinal Interbody Implant NuVasive Launches TLX 20 Degree Expandable Spinal Interbody Implant
    SpinalCyte LLC Issued New U.S. Patent SpinalCyte LLC Issued New U.S. Patent
    Initial Cases with Centinel Spine Initial Cases with Centinel Spine's FLX 3D Printed All-Titanium Interbodies Completed
    7. NuVasive Inc. 7. NuVasive Inc.
    Aziyo Partners with SurGenTec for Minimally Invasive Bone Graft Delivery Aziyo Partners with SurGenTec for Minimally Invasive Bone Graft Delivery
    OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan
    RTI Surgical Launches Fortilink-TS and -L IBF Systems RTI Surgical Launches Fortilink-TS and -L IBF Systems
    FDA OKs Centinel Spine FDA OKs Centinel Spine's FLX Platform of 3D Printed All-Titanium Interbodies
    SpinalCyte Applies to FDA to Expand Human Clinical Trial of CybroCell Dermal Fibroblasts SpinalCyte Applies to FDA to Expand Human Clinical Trial of CybroCell Dermal Fibroblasts

    Related Breaking News

    • Extremities
      FDA OKs Shoulder Innovations

      FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

      The new InSet Plus glenoids feature an angled articular surface.
      PR Newswire 12.10.19

    • Trauma/Sports
      OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

      OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

      Trauma application added to universal PhantomMSK platform; one platform with use across a variety of procedures.
      OrthoGrid 12.10.19

    • Tyber Medical Opens $8M Office and Manufacturing Facility

      Tyber Medical Opens $8M Office and Manufacturing Facility

      Creates about 30 additional jobs for Lehigh Valley's second-fastest growing company.
      PR Newswire 12.10.19


    • Extremities | Software & Quality
      FDA OKs Shoulder Surgery 3D Planner & Positioner

      FDA OKs Shoulder Surgery 3D Planner & Positioner

      Intuitive, surgeon-driven software provides 3D pre-operative planning and 3D positioners for intra-operative positioning.
      PR Newswire 12.10.19

    • Spine/Neurology
      Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

      Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

      Patient enrollment in this U.S. study will now continue through completion of 60 total subjects.
      PR Newswire 12.10.19

    • Spine/Neurology
      InVivo Therapeutics Attains 25 Percent Enrollment in Spinal Cord Injury Study

      InVivo Therapeutics Attains 25 Percent Enrollment in Spinal Cord Injury Study

      Fourteen sites currently are open for patient enrollment.
      Business Wire 12.09.19


    • BioPrax Biofilm Disruption Device Granted FDA Breakthrough Device Designation

      BioPrax Biofilm Disruption Device Granted FDA Breakthrough Device Designation

      Product is designed to help eliminate biofilm infections on prosthetic knee implants during early intervention procedures.
      PR Newswire 12.09.19

    • Spine/Neurology
      Orthofix Appoints New Spine Business Leader

      Orthofix Appoints New Spine Business Leader

      Kevin Kenny was previously VP of U.S. sales for Spine and Biologics at Medtronic.
      Business Wire 12.05.19

    • Packaging & Sterilization
      Viant to Halt EtO Sterilization at Michigan Plant by End of Year

      Viant to Halt EtO Sterilization at Michigan Plant by End of Year

      EGLE had been investigating over the past year and issued Viant several violations for inadequate capture and control of ethylene oxide emissions.
      Michigan Department of Environment, Great Lakes, and Energy (EGLE) 12.04.19


    • Spine/Neurology
      Synaptive Medical

      Synaptive Medical's Modus V Expands Into Spine Market

      Modus V’s robotic arm moves automatically based on the positions of tracked surgical instruments.
      Business Wire 12.04.19

    • 3-D Printing/Additive Mfg. | Biologics | Materials
      3D-Printed Graftless Bone Transplants Go to Clinical Trials

      3D-Printed Graftless Bone Transplants Go to Clinical Trials

      ADAM is piloting the use of ceramics and polymer in 3D-printed bone implants, able to be produced at commodity prices.
      PR Newswire 12.04.19

    • Extremities
      CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

      CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

      The add-on acquisition furthers CrossRoads' strategy to build a market-leading company in the high-growth orthopedic extremities sector.
      PR Newswire 12.04.19

    • Spine/Neurology
      Micro Spine Implant Could Restore Standing and Walking

      Micro Spine Implant Could Restore Standing and Walking

      Hair-like electrical wires send electrical signals to trigger networks that already know how to do the hard work.
      University of Alberta Faculty of Medicine & Dentistry 12.03.19

    • Spine/Neurology
      RTI Surgical Appoints New Division Leaders

      RTI Surgical Appoints New Division Leaders

      Terry Rich, experienced spine leader, named president, Global Spine; Olivier Visa elevated to president, Global OEM.
      GlobeNewswire 12.03.19

    • KCI Introduces Solution for Challenging Surgical Locations

      KCI Introduces Solution for Challenging Surgical Locations

      Company's latest technology targets post-operative incisions and surrounding soft tissue.
      Business Wire 12.03.19


    Breaking News
    • FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    • OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    • Tyber Medical Opens $8M Office and Manufacturing Facility
    • FDA OKs Shoulder Surgery 3D Planner & Positioner
    • Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Celmatix Sues Research Partner 23andMe for $100M
    MedStar Health and Cleveland Clinic Innovations Awarded Grant
    FDA Cleared New Cochlear Osia 2 System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Mark Andy joins forces with UPM Raflatac
    Omet India opens in New Delhi
    Siegwerk opens Europe's largest, fully-automated ink facility
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    NDC Appoints President
    AATC Adds Two Scholarships
    Archroma Names CEO
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Tyber Medical Opens $8M Office and Manufacturing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.